ERBB2 and triple-negative breast carcinoma: In addition, a pooled analysis of 4 neoadjuvant studies11 demonstrated that patients with ERBB2-low BC had improved OS compared with patients with ERBB2-zero BC, and this was noted in a subgroup with triple-negative breast cancer (TNBC) as well.